1. Home
  2. GKOS vs EEFT Comparison

GKOS vs EEFT Comparison

Compare GKOS & EEFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • EEFT
  • Stock Information
  • Founded
  • GKOS 1998
  • EEFT 1994
  • Country
  • GKOS United States
  • EEFT United States
  • Employees
  • GKOS N/A
  • EEFT N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • EEFT EDP Services
  • Sector
  • GKOS Health Care
  • EEFT Technology
  • Exchange
  • GKOS Nasdaq
  • EEFT Nasdaq
  • Market Cap
  • GKOS 5.8B
  • EEFT 4.7B
  • IPO Year
  • GKOS 2015
  • EEFT 1997
  • Fundamental
  • Price
  • GKOS $89.83
  • EEFT $95.96
  • Analyst Decision
  • GKOS Strong Buy
  • EEFT Buy
  • Analyst Count
  • GKOS 12
  • EEFT 6
  • Target Price
  • GKOS $131.17
  • EEFT $123.83
  • AVG Volume (30 Days)
  • GKOS 1.2M
  • EEFT 700.4K
  • Earning Date
  • GKOS 07-30-2025
  • EEFT 07-30-2025
  • Dividend Yield
  • GKOS N/A
  • EEFT N/A
  • EPS Growth
  • GKOS N/A
  • EEFT 26.28
  • EPS
  • GKOS N/A
  • EEFT 7.31
  • Revenue
  • GKOS $432,953,000.00
  • EEFT $4,136,399,999.00
  • Revenue This Year
  • GKOS $27.88
  • EEFT $10.58
  • Revenue Next Year
  • GKOS $27.76
  • EEFT $8.09
  • P/E Ratio
  • GKOS N/A
  • EEFT $13.29
  • Revenue Growth
  • GKOS 26.70
  • EEFT 8.71
  • 52 Week Low
  • GKOS $77.10
  • EEFT $85.24
  • 52 Week High
  • GKOS $163.71
  • EEFT $114.25
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 43.89
  • EEFT 44.54
  • Support Level
  • GKOS $88.94
  • EEFT $90.00
  • Resistance Level
  • GKOS $92.70
  • EEFT $98.27
  • Average True Range (ATR)
  • GKOS 3.82
  • EEFT 3.36
  • MACD
  • GKOS 0.38
  • EEFT 0.30
  • Stochastic Oscillator
  • GKOS 46.71
  • EEFT 37.58

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About EEFT Euronet Worldwide Inc.

Euronet Worldwide Inc is a provider of electronic financial transaction solutions. It offers payment and transaction processing and distribution solutions to financial institutions, retailers, service providers, and individual consumers. The company's product offerings include comprehensive ATM, POS, card outsourcing, card issuing and merchant acquiring services, software solutions, money transfer services, etc. Its reportable operating segments are EFT Processing, epay, and Money Transfer. Maximum revenue is derived from its Money Transfer segment, which provides money transfer services across the world under the brand names Ria, AFEX, IME, and xe. Geographically, the company generates maximum revenue from the United States, followed by Germany, India, France, Greece, and other regions.

Share on Social Networks: